Pinnacle Wealth Planning Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$30.9K	Buy	1,199 +34	+3%	+$735	﹤0.01%	1571
2026 Q2	$23.5K	Buy	1,165 +882	+312%	+$17.8K	﹤0.01%	1706
2026 Q1	$5.54K	Sell	283 -1,332	-82%	-$32.6K	﹤0.01%	2232
2025 Q4	$43.2K	Buy	+1,615	New	+$41.6K	﹤0.01%	1299
2021 Q1	–	Sell	-230	Closed	-$5K	–	419
2020 Q4	$5K	Buy	+230	New	+$4.48K	﹤0.01%	1634

Other funds holding AMPH

Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

LAM Group Lake Oswego, Oregon $199M AUM 14.21% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

Illumine Investment Management Poulsbo, Washington $144M AUM 33.61% 1-Year Est. Return

Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return

Pinnacle Wealth Planning Services's AMPH Position: Q3 2026 in Review

Pinnacle Wealth Planning Services increased its Amphastar Pharmaceuticals (AMPH) stake by 2.9% in Q3 2026, buying an estimated $735 and bringing the position to 1,199 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1571.

Pinnacle Wealth Planning Services first reported a position in AMPH in Q4 2020 and has held it in 5 quarters since. The position peaked at $43.2K in Q4 2025. 58 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

Pinnacle Wealth Planning Services held 1,199 shares of Amphastar Pharmaceuticals worth $30.9K as of Q3 2026.
Pinnacle Wealth Planning Services bought 34 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $735.
Amphastar Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #1571 holding.
Pinnacle Wealth Planning Services first reported a position in Amphastar Pharmaceuticals in Q4 2020 and has held it in 5 quarters since.
Pinnacle Wealth Planning Services's Amphastar Pharmaceuticals position peaked at $43.2K in Q4 2025.
58 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.